Our DFG-Emmy Noether Program-funded lab has two main focuses: First, we are developing in vivo tissue regeneration as a therapeutic strategy. Second, we aim to understand the dynamics between hematopoietic and hepatic systems in development and disease using blood-liver organoids.
The Berlin Institute of Health Center for Regenerative Therapies (BIH-CRT), Cluster Health Capital Berlin-Brandenburg, German Heart Center at Charité (DHZC) and Berlin Partner hosted the 10th RegMed Forum on November 23, 2023, at the Cranach Haus. The forum's primary objective was to engage various stakeholders in a meaningful dialogue about…
Univ. Prof. Dr Georg Duda was honoured by the DGU's Johann Friedrich Dieffenbach Bust on 23 October 2023 as part of the German Congress of Orthopaedics and Trauma Surgery (DKOU) 2023 for his special achievements to trauma surgery. The Dieffenbach Bust was established in 1982 as an honourable award for scientific services to trauma medicine. It is…
The research group Model Systems for Regenerative Therapies leverages interdisciplinary approaches to interdisciplinary and translational research. Our goal is to improve our mechanistic pathophysiological understanding regarding musculoskeletal fibrosis to a level where we can offer effective solutions for clinical applications.
Infectious diseases remain one of the major causes of death world-wide. Emerging infections, such as the COVID-19 pandemic or the MPVX outbreak, but also the dramatic increase in antibiotic resistance illustrate the urgent need for novel antimicrobial interventions. Vaccines represent one of the most powerfull, safe and cost-effective tools to…
Additive manufacturing (AM) technologies could be the leverage for the generation of precise and personalized scaffold constructs enabling improved bone regeneration and remodeling outcomes. Our team strives to develop methodologies and generate knowledge that could lead to mechanistic understanding of scaffold-guided bone defect regeneration…
The objective of our research group is to acquire the basic knowledge necessary to develop new therapies against diseases affecting the liver. For that, we use stem cells to model embryonic development in vitro and to produce liver cells with an interest for cell therapy.
Tissues in the musculoskeletal system are exquisitely designed with superb mechanical properties. The tissues are also able to adapt to withstand changing mechanical conditions. The Computational Mechanobiology Group is focused on understanding these two exciting features. Using computer modeling techniques, we seek to understand the mechanical…
Content will follow shortly